Marta Simó

ORCID: 0000-0002-6787-1949

Also affiliated with Institut d'Investigació Biomédica de Bellvitge

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)”.

Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)

Journal of Clinical Oncology(2023)10.1200/jco.22.02561

N/A

0.708DataRank · unranked

111 citations

Delvys Rodríguez‐Abreu, Marta Simó, Bartomeu Massutí, Óscar Juan, Gerardo Huidobro +13 more

Mapping Lesion-Related Epilepsy to a Human Brain Network

JAMA Neurology(2023)10.1001/jamaneurol.2023.1988

N/A

0DataRank · unranked

112 citations

Janne Nordberg, Alexander L. Cohen, Christopher Lin, Joey Hsu, Andreas Horn +25 more